Genetic Testing Market in APAC to Grow by USD 1.31 Bn

NEW YORK, Feb. 18, 2022 /PRNewswire/ — The genetic testing market in APAC is expected to grow by USD 1.31 bn from 2021 to 2026. Technavio estimates that the market will progress at a CAGR of 13.21%. This report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

Find out key information regarding the genetic testing market in APAC. Read Free Sample Report

Genetic Testing Market in APAC 2022-2026: Scope

The report also covers the following areas:

Genetic Testing Market in APAC 2022-2026: Segmentation

By product, the genetic testing market in APAC has been segmented into equipment and consumables. The equipment segment will have significant market share growth during the forecast period. The use of automated genetic equipment in clinical diagnostic laboratories has helped in reducing the workload, increasing accuracy, and improving the efficiency of clinicians by automating deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) purification, isolation, and amplification processes. The rising demand for early disease diagnosis, along with the availability of advanced genetic testing equipment, is expected to fuel the revenue growth of the equipment segment during the forecast period.

By application, the market has been segmented into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others. The cancer diagnosis segment will have significant market share growth during the forecast period. Genetic tests and devices for various types of cancer are increasing significantly. It is necessary to have a broad product portfolio to meet the requirement of diagnosing various cancers.

Learn about the contribution of each segment of the market. View Our Free Sample Report Now

Genetic Testing Market in APAC 2022-2026: Vendor Analysis and Scope

Story continues

To help businesses improve their market position, Technavio’s report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments while maintaining their positions in the slow-growing segments.

Some of the major vendors of the genetic testing market in APAC include Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., Mapmygenome India Ltd., Myriad Genetics Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. The key offerings of some of these vendors are listed below:

• Abbott Laboratories – The company offers genetic testing products such as Vysis CEP 12 SpectrumOrange DNA Probe Kit and Vysis CEP 8 SpectrumOrange DNA Probe Kit.

• Bio Rad Laboratories Inc. – The company offers genetic testing products such as pGLO Bacterial Transformation kit, elegans Behavior kit, and others.

• Danaher Corp. – The company offers genetic testing products such as Xpert BCR-ABL Ultra and Xpert Bladder Cancer Detection.

Get lifetime access to our Technavio Insights. Subscribe now to our most popular “Lite Plan” billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!

Genetic Testing Market in APAC 2022-2026: Key Highlights

• CAGR of the market during the forecast period 2022-2026

• Detailed information on factors that will assist genetic testing market growth in APAC during the next five years

• Estimation of the genetic testing market size in APAC and its contribution to the parent market

• Predictions on upcoming trends and changes in consumer behavior

• The growth of the genetic testing market in APAC

• Analysis of the market’s competitive landscape and detailed information on vendors

• Comprehensive details of factors that will challenge the growth of genetic testing market vendors in APAC

Related Reports:

Single Cell Analysis Market by Product and Geography – Forecast and Analysis 2022-2026

Brain Tumor Diagnostics Market by Type and Geography – Forecast and Analysis 2022-2026

For more valuable insights, Download Latest Free Sample Report

Table of Contents

1. Executive Summary

1.1 Market Overview

Exhibit 01: Key Finding 1

Exhibit 02: Key Finding 2

Exhibit 03: Key Finding 5

Exhibit 04: Key Finding 6

Exhibit 05: Key Finding 7

2. Market Landscape

2.1 Market ecosystem

2.1.1 Parent Market

Exhibit 06: Parent market

Exhibit 07: Market characteristics

2.2 Value chain analysis

Exhibit 08: Value chain analysis: Healthcare Equipment Market

2.2.1 Research and development

2.2.2 Inputs

2.2.3 Operations

2.2.4 Distribution

2.2.5 Marketing and sales

2.2.6 Post-sales and services

2.2.7 Industry innovations

3. Market Sizing

3.1 Market definition

Exhibit 09: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 10: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021 – 2026

Exhibit 11: Global – Market size and forecast 2021 – 2026 ($ million)

Exhibit 12: Global market: Year-over-year growth 2021 – 2026 (%)

4. Five Forces Analysis

4.1 Five Forces Summary

Exhibit 13: Five forces analysis 2021 & 2026

4.2 Bargaining power of buyers

Exhibit 14: Bargaining power of buyers

4.3 Bargaining power of suppliers

Exhibit 15: Bargaining power of suppliers

4.4 Threat of new entrants

Exhibit 16: Threat of new entrants

4.5 Threat of substitutes

Exhibit 17: Threat of substitutes

4.6 Threat of rivalry

Exhibit 18: Threat of rivalry

4.7 Market condition

Exhibit 19: Market condition – Five forces 2021

5.Market Segmentation by Product

5.1 Market segments

Exhibit 20: Product – Market share 2021-2026 (%)

5.2 Comparison by Product

Exhibit 21: Comparison by Product

5.3 Equipment – Market size and forecast 2021-2026

Exhibit 22: Equipment – Market size and forecast 2021-2026 ($ million)

Exhibit 23: Equipment – Year-over-year growth 2021-2026 (%)

5.4 Consumables – Market size and forecast 2021-2026

Exhibit 24: Consumables – Market size and forecast 2021-2026 ($ million)

Exhibit 25: Consumables – Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Product

Exhibit 26: Market opportunity by Product

6 Market Segmentation by Application

6.1 Market segments

Exhibit 27: Application – Market share 2021-2026 (%)

6.2 Comparison by Application

Exhibit 28: Comparison by Application

6.3 Cancer diagnosis – Market size and forecast 2021-2026

Exhibit 29: Cancer diagnosis – Market size and forecast 2021-2026 ($ million)

Exhibit 30: Cancer diagnosis – Year-over-year growth 2021-2026 (%)

6.4 Genetic disease diagnosis – Market size and forecast 2021-2026

Exhibit 31: Genetic disease diagnosis – Market size and forecast 2021-2026 ($ million)

Exhibit 32: Genetic disease diagnosis – Year-over-year growth 2021-2026 (%)

6.5 Cardiovascular disease diagnosis – Market size and forecast 2021-2026

Exhibit 33: Cardiovascular disease diagnosis – Market size and forecast 2021-2026 ($ million)

Exhibit 34: Cardiovascular disease diagnosis – Year-over-year growth 2021-2026 (%)

6.6 Others – Market size and forecast 2021-2026

Exhibit 35: Others – Market size and forecast 2021-2026 ($ million)

Exhibit 36: Others – Year-over-year growth 2021-2026 (%)

6.7 Market opportunity by Application

Exhibit 37: Market opportunity by Application

7. Customer landscape

7.1 Overview

Exhibit 38: Customer landscape

8. Drivers, Challenges, and Trends

8.1 Market drivers

8.1.1 Rising approval of advanced genetic testing products

8.1.2 Increasing application of genetic testing in oncology

8.1.3 Rising strategic partnership

8.2 Market challenges

8.2.1 Varying regulations on genetic testing and research

8.2.2 High cost of genetic testing

8.2.3 Social and ethical implications of genetic testing

Exhibit 39: Impact of drivers and challenges

8.3 Market trends

8.3.1 Advancements in next-generation sequencing

8.3.2 Rising adoption of genetic tests for COVID-19

8.3.3 Growing adoption of pharmacogenetic testing in reducing adverse drug events

9. Vendor Landscape

9.1 Overview

Exhibit 40: Vendor landscape

9.2 Vendor Disruption

Exhibit 41: Landscape disruption

Exhibit 42: Industry risks

9.3 Competitive Scenario

10. Vendor Analysis

10.1 Vendors covered

Exhibit 43: Vendors covered

10.2 Market positioning of vendors

Exhibit 44: Market positioning of vendors

10.3 Abbott Laboratories

Exhibit 45: Abbott Laboratories – Overview

Exhibit 46: Abbott Laboratories – Business segments

Exhibit 47: Abbott Laboratories – Key news

Exhibit 48: Abbott Laboratories – Key offerings

Exhibit 49: Abbott Laboratories – Segment focus

10.4 Bio Rad Laboratories Inc.

Exhibit 50: Bio Rad Laboratories Inc. – Overview

Exhibit 51: Bio Rad Laboratories Inc. – Business segments

Exhibit 52: Bio Rad Laboratories Inc. – Key news

Exhibit 53: Bio Rad Laboratories Inc. – Key offerings

Exhibit 54: Bio Rad Laboratories Inc. – Segment focus

10.5 Danaher Corp.

Exhibit 55: Danaher Corp. – Overview

Exhibit 56: Danaher Corp. – Business segments

Exhibit 57: Danaher Corp. – Key news

Exhibit 58: Danaher Corp. – Key offerings

Exhibit 59: Danaher Corp. – Segment focus

10.6 Exact Sciences…